Smoking cessation or nicotine de-addiction involves tobacco discontinuation. Tobacco contains nicotine that causes addiction by releasing the neurotransmitters such as glutamate, dopamine and gamma-aminobutyric acid (GABA). Cigarette and tobacco addicts can be better treated with smoking cessation products.
Based on the Cessation and Nicotine De-Addiction market development status, competitive landscape and development model in different regions of the world, this report is dedicated to providing niche markets, potential risks and comprehensive competitive strategy analysis in different fields. From the competitive advantages of different types of products and services, the development opportunities and consumption characteristics and structure analysis of the downstream application fields are all analyzed in detail. To Boost Growth during the epidemic era, this report analyzes in detail for the potential risks and opportunities which can be focused on.
In Chapter 2.4 of the report, we share our perspectives for the impact of COVID-19 from the long and short term.
In chapter 3.4, we provide the influence of the crisis on the industry chain, especially for marketing channels.
In chapters 8-13, we update the timely industry economic revitalization plan of the country-wise government.
Key players in the global Cessation and Nicotine De-Addiction market covered in Chapter 5:
Novartis AG
Smoke Away
Fontem Ventures
Johnson & Johnson
Kimree Technology Co.
V2 Electronic Cigarettes
Dr. Reddy’s Laboratories
GSK
Mig Vapor
Pfizer
Perrigo Company
VaporFi
The Harvard Drug Group
Halo Cigs
In Chapter 6, on the basis of types, the Cessation and Nicotine De-Addiction market from 2015 to 2025 is primarily split into:
Drug therapy
Nicotine Replacement Therapy (NRT)
Electronic cigarettes (E-cigarettes)
Others
In Chapter 7, on the basis of applications, the Cessation and Nicotine De-Addiction market from 2015 to 2025 covers:
Men
Women
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 8-13:
North America (Covered in Chapter 9)
United States
Canada
Mexico
Europe (Covered in Chapter 10)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 11)
China
Japan
South Korea
Australia
India
South America (Covered in Chapter 12)
Brazil
Argentina
Columbia
Middle East and Africa (Covered in Chapter 13)
UAE
Egypt
South Africa
Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025
Table of Content
1 Market Overview
1.1 Product Definition and Market Characteristics
1.2 Global Cessation and Nicotine De-Addiction Market Size
1.3 Market Segmentation
1.4 Global Macroeconomic Analysis
1.5 SWOT Analysis
2. Market Dynamics
2.1 Market Drivers
2.2 Market Constraints and Challenges
2.3 Emerging Market Trends
2.4 Impact of COVID-19
2.4.1 Short-term Impact
2.4.2 Long-term Impact
3 Associated Industry Assessment
3.1 Supply Chain Analysis
3.2 Industry Active Participants
3.2.1 Suppliers of Raw Materials
3.2.2 Key Distributors/Retailers
3.3 Alternative Analysis
3.4 The Impact of Covid-19 From the Perspective of Industry Chain
4 Market Competitive Landscape
4.1 Industry Leading Players
4.2 Industry News
4.2.1 Key Product Launch News
4.2.2 M&A and Expansion Plans
5 Analysis of Leading Companies
5.1 Novartis AG
5.1.1 Novartis AG Company Profile
5.1.2 Novartis AG Business Overview
5.1.3 Novartis AG Cessation and Nicotine De-Addiction Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.1.4 Novartis AG Cessation and Nicotine De-Addiction Products Introduction
5.2 Smoke Away
5.2.1 Smoke Away Company Profile
5.2.2 Smoke Away Business Overview
5.2.3 Smoke Away Cessation and Nicotine De-Addiction Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.2.4 Smoke Away Cessation and Nicotine De-Addiction Products Introduction
5.3 Fontem Ventures
5.3.1 Fontem Ventures Company Profile
5.3.2 Fontem Ventures Business Overview
5.3.3 Fontem Ventures Cessation and Nicotine De-Addiction Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.3.4 Fontem Ventures Cessation and Nicotine De-Addiction Products Introduction
5.4 Johnson & Johnson
5.4.1 Johnson & Johnson Company Profile
5.4.2 Johnson & Johnson Business Overview
5.4.3 Johnson & Johnson Cessation and Nicotine De-Addiction Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.4.4 Johnson & Johnson Cessation and Nicotine De-Addiction Products Introduction
5.5 Kimree Technology Co.
5.5.1 Kimree Technology Co. Company Profile
5.5.2 Kimree Technology Co. Business Overview
5.5.3 Kimree Technology Co. Cessation and Nicotine De-Addiction Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.5.4 Kimree Technology Co. Cessation and Nicotine De-Addiction Products Introduction
5.6 V2 Electronic Cigarettes
5.6.1 V2 Electronic Cigarettes Company Profile
5.6.2 V2 Electronic Cigarettes Business Overview
5.6.3 V2 Electronic Cigarettes Cessation and Nicotine De-Addiction Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.6.4 V2 Electronic Cigarettes Cessation and Nicotine De-Addiction Products Introduction
5.7 Dr. Reddy’s Laboratories
5.7.1 Dr. Reddy’s Laboratories Company Profile
5.7.2 Dr. Reddy’s Laboratories Business Overview
5.7.3 Dr. Reddy’s Laboratories Cessation and Nicotine De-Addiction Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.7.4 Dr. Reddy’s Laboratories Cessation and Nicotine De-Addiction Products Introduction
5.8 GSK
5.8.1 GSK Company Profile
5.8.2 GSK Business Overview
5.8.3 GSK Cessation and Nicotine De-Addiction Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.8.4 GSK Cessation and Nicotine De-Addiction Products Introduction
5.9 Mig Vapor
5.9.1 Mig Vapor Company Profile
5.9.2 Mig Vapor Business Overview
5.9.3 Mig Vapor Cessation and Nicotine De-Addiction Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.9.4 Mig Vapor Cessation and Nicotine De-Addiction Products Introduction
5.10 Pfizer
5.10.1 Pfizer Company Profile
5.10.2 Pfizer Business Overview
5.10.3 Pfizer Cessation and Nicotine De-Addiction Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.10.4 Pfizer Cessation and Nicotine De-Addiction Products Introduction
5.11 Perrigo Company
5.11.1 Perrigo Company Company Profile
5.11.2 Perrigo Company Business Overview
5.11.3 Perrigo Company Cessation and Nicotine De-Addiction Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.11.4 Perrigo Company Cessation and Nicotine De-Addiction Products Introduction
5.12 VaporFi
5.12.1 VaporFi Company Profile
5.12.2 VaporFi Business Overview
5.12.3 VaporFi Cessation and Nicotine De-Addiction Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.12.4 VaporFi Cessation and Nicotine De-Addiction Products Introduction
5.13 The Harvard Drug Group
5.13.1 The Harvard Drug Group Company Profile
5.13.2 The Harvard Drug Group Business Overview
5.13.3 The Harvard Drug Group Cessation and Nicotine De-Addiction Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.13.4 The Harvard Drug Group Cessation and Nicotine De-Addiction Products Introduction
5.14 Halo Cigs
5.14.1 Halo Cigs Company Profile
5.14.2 Halo Cigs Business Overview
5.14.3 Halo Cigs Cessation and Nicotine De-Addiction Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.14.4 Halo Cigs Cessation and Nicotine De-Addiction Products Introduction
6 Market Analysis and Forecast, By Product Types
6.1 Global Cessation and Nicotine De-Addiction Sales, Revenue and Market Share by Types (2015-2020)
6.1.1 Global Cessation and Nicotine De-Addiction Sales and Market Share by Types (2015-2020)
6.1.2 Global Cessation and Nicotine De-Addiction Revenue and Market Share by Types (2015-2020)
6.1.3 Global Cessation and Nicotine De-Addiction Price by Types (2015-2020)
6.2 Global Cessation and Nicotine De-Addiction Market Forecast by Types (2020-2025)
6.2.1 Global Cessation and Nicotine De-Addiction Market Forecast Sales and Market Share by Types (2020-2025)
6.2.2 Global Cessation and Nicotine De-Addiction Market Forecast Revenue and Market Share by Types (2020-2025)
6.3 Global Cessation and Nicotine De-Addiction Sales, Price and Growth Rate by Types (2015-2020)
6.3.1 Global Cessation and Nicotine De-Addiction Sales, Price and Growth Rate of Drug therapy
6.3.2 Global Cessation and Nicotine De-Addiction Sales, Price and Growth Rate of Nicotine Replacement Therapy (NRT)
6.3.3 Global Cessation and Nicotine De-Addiction Sales, Price and Growth Rate of Electronic cigarettes (E-cigarettes)
6.3.4 Global Cessation and Nicotine De-Addiction Sales, Price and Growth Rate of Others
6.4 Global Cessation and Nicotine De-Addiction Market Revenue and Sales Forecast, by Types (2020-2025)
6.4.1 Drug therapy Market Revenue and Sales Forecast (2020-2025)
Summary: Get latest Market Research Reports on Cessation and Nicotine De-Addiction. Industry analysis & Market Report on Cessation and Nicotine De-Addiction is a syndicated market report, published as Global Cessation and Nicotine De-Addiction Market Research Report with Opportunities and Strategies to Boost Growth- COVID-19 Impact and Recovery. It is complete Research Study and Industry Analysis of Cessation and Nicotine De-Addiction market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.